Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania

Malaria Journal

Volumn 5, Issue , 2006, Pages

  Mbugi, Erasto V ^a,b,d   Mutayoba, Benezeth M ^a   Malisa, Allen L ^a   Balthazary, Sakurani T ^a   Nyambo, Thomas B ^b   Mshinda, Hassan ^c  

^a SOKOINE UNIVERSITY OF AGRICULTURE   (Tanzania)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^c IFAKARA HEALTH INSTITUTE   (Tanzania)

^d WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; FANSIDAR;

ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD SAMPLING; CODON; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA; MALE; PLASMODIUM FALCIPARUM; POINT MUTATION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PROTEIN DOMAIN; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TANZANIA;

ANIMALS; ANTIMALARIALS; CHILD, PRESCHOOL; DIHYDROPTEROATE SYNTHASE; DRUG COMBINATIONS; DRUG RESISTANCE; FEMALE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PYRIMETHAMINE; SULFADOXINE; TANZANIA; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 33751019978     PISSN: 14752875     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-5-94     Document Type: Article

References (48)

1. Le Bras J, Durand R: The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum. Fundam Clin Pharmacol 2003, 17:147-153.
2. Yuvaniyama J, Chitnumsub P, Kamchonwongpaisan S, Vanichtanankul J, Sirawaraporn W, Taylor P, Walkinshaw MD, Yuthavong Y: Insights into antifolate resistance from malarial DHFR-TS structures. Nat Struct Biol 2003, 10:357-365.
3. Sirawaraporn W, Sathitkul T, Sirawaraporn R, Yuthavong Y, Santi DV: Antifolate-resistance mutants of Plasmodium falciparum dihydrofolate reductase. Proc Natl Acad Sci USA 1997, 94:1124-1129.
4. Triglia T, Cowman AF: Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proc Natl Acad Sci USA 1994, 91:7149-7153.
5. Peterson DS, Milhous WK, Wellems TE: Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum. Proc Natl Acad Sci USA 1990, 87:3018-3022.
6. Wang P, Lee CS, Bayoumi R, Djimde A, Doumbo O, Swedberg G, Dao LD, Mshinda H, Tanner M, Watkins WM, Sims PF, Hyde JE: Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins. Mol Biochem Parasitol 1997, 89:161-177.
7. Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JS, Martino LM, Mukadam RAG, Rogerson SJ, Lescano AG, Molyneux ME, Winstanley PA, Chimpeni P, Taylor TE, Plowe CV: Molecular markers for failure of sulphadoxine- pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis 2002, 185:380-388.
8. Kublin JG, Witzig RS, Shankar AH, Zurita JQ, Gilman RH, Guarda JA, Cortese JF, Plowe CV: Molecular assays for surveillance of antifolate-resistant malaria. Lancet 1998, 351:1629-1630.
9. Plowe CV, Joseph FC, Abdoulaye D, Okey CN, William MW, Peter AW, Jose GEF, Rene EM, Juan CA, Jose LC, Darrick C, Ogobara KD: Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulphadoxine use and resistance. J Infect Dis 1997, 176:1590-1596.
10. De Pecoulas PE, Basco LK, Abdullah B, Dje MK, Le Bras J, Mazabraud A: Plasmodium falciparum : detection of antifolate resistance by mutation specific restriction enzyme digestion. Exp Parasitol 1995, 80:483-487.
11. Wang P, Brooks DR, Sims PFG, Hyde JE: A mutation-specific PCR system to detect sequence variation in the dihydropteroate synthetase gene of Plasmodium falciparum. Mol Biochem Parasitol 1995, 71:115-125.
12. Gyang FN, Peterson DS, Wellems TE: Plasmodium falciparum, rapid detection of dihydofolate reductase mutations that confer resistance to cycloguanil and pyrimethamine. Exp Parasitol 1992, 74:470-472.
13. Misra SP: In-vivo resistance to chloroquine and sulphadoxine- pyrimethamine combination in Plasmodium falciparum in India. Proc Natl Acad Sci India 1996, 66:123-138.
14. Basco L: Molecular epidemiology of malaria in Cameroun. XII. In vitro drug assays and molecular surveillance of chloroquine and proguanil resistance. Am J Trop Med Hyg 2002, 67:383-387.
15. Mugittu K, Ndejembi M, Malisa A, Lemnge M, Premji Z, Mwita A, Nkya W, Kataraihya J, Abdulla S, Beck H-P, Mshinda H: Therapeutic efficacy of sulphadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance. Am J Trop Med Hyg 2004, 71:696-702.
16. Biswas S: Association of antifolate resistance in vitro and point mutations in dihydrofolate reductase and dihydropteroate synthetase gene of Plasmodium falciparum. J Postgrad Med 2004, 50:17-20.
17. Pearce RJ, Drakeley C, Chandramohan D, Mosha F, Roper C: Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania. Antimicrob Agents Chemother 2003, 47:1347-1354.
18. Mockenhaupt FP, Ehrhardt S, Dzisi SY, Bousema JT, Wassilew N, Schreiber J, Anemana SD, Cramer JP, Otchwemah RN, Sauerwein RW, Eggelte TA, Bienzle U: A randomized, placebo-controlled, double-blind trial on sulphadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malaria. Trop Med Int Health 2005, 10:512-520.
19. Danis M, Bricaire F: The new drug combinations: their place in the treatment of uncomplicated Plasmodium falciparum malaria. Fundam Clin Pharmacol 2003, 17:155-160.
20. Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE: Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg 1995, 52:565-568.
21. Duraisingh TM, Curtis J, Warhurst DC: Plasmodium falciparum : Detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthase genes by PCR and restriction digestion. Exp Parasitol 1998, 89:1-8.
22. Kyabayinze D, Cattamanchi A, Kamya MR, Rosenthal PJ, Dorsey G: Validation of a simplified method for using molecular markers to predict sulphadoxine-pyrimethamine treatment failure in African children with falciparum malaria. Am J Trop Med Hyg 2003, 69:247-252.
23. Jelinek K, Kilian AH, Kabagambe G, von Sonnenburg F: Plasmodium falciparum resistance to sulphadoxine-pyrimethamine in Uganda: correlation with polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes. Am J Trop Med Hyg 1999, 61:463-466.
24. Sambrook J, Fritch EF, Maniatis T: Molecular cloning: a laboratory manual 2nd edition. Cold spring Harbour Laboratory Press, New York; 1989:6.0-6.62.
25. Aubouy A, Jafari S, Huart V, Migot-Nabias F, Mayombo J, Durand R, Bakary M, Le Bras J, Deloron P: dhfr and dhps genotypes of Plasmodium falciparum isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but not with sulphadoxine-pyrimethamine treatment efficacy. J Antimicrob Chemother 2003, 52:43-49.
26. World Health Organization (2003): Microbiology & Immunology: BS2024: Malaria. [http://www-micro.msb.le.ac.uk/224/malaria.html].
27. Felger I, Irion A, Steiger S, Beck H-P: Epidemiology ofmultiple Plasmodium falciparum infections: Genotypes of merozoite-surface protein 2 of Plasmodium falciparum in Tanzania. Trans R Soc Trop Med Hyg 1999, 93(Suppl 1):3-9.
28. Basco LK, Tahar R, Keundjian A, Ringwald P: Sequence variations in the genes encoding dihydropteroate synthase and dihydrofolate reductase and clinical response to sulphadoxine-pyrimethamine in patients with acute uncomplicated falciparum malaria. J Infect Dis 2000, 182:624-628.
29. Nzila AM, Nduati E, Mberu EK, Hopkins SC, Monks SA, Winstanley PA, Watkins WM: Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate pyrimethamine-sulphadoxine compared with the shorter-acting chlorproguanil-dapsone on Kenyan Plasmodium falciparum. J Infect Dis 2000, 181:2003-2028.
30. Omar SA, Adagu IS, Warhurst DC: Can pre-treatment screening for dhps and dhfr point mutations in Plasmodium falciparum infections be used to predict sulphadoxine-pyrimethamine treatment failure? Trans R Soc Trop Med Hyg 2001, 95:315-319.
31. Alifrangis M, Enosse S, Khalil IF, Tarimo DS, Lemnge MM, Thompson R, Bygbjerg IC, Rønn AM: Prediction of Plasmodium falciparum resistance to sulphadoxine-pyrimethamine in vivo by mutations in the dihydrofolate reductase and dihydropteroate synthase genes: A comparative study between sites of differing endemicity. Am J Trop Med Hyg 2003, 69:601-606.
32. Kitua AY: Malaria of P. falciparum : Facts on unsolved problems. In Report of the Interdisciplinary Workshop and PhD Course Edited by: Blegvad L. et al. Arusha Tanzania:5-6. 17 - 25 January 2000
33. Mshinda H: The status of, and development of, resistance to antimalarials in an area of high perennial transmission. PhD Degree of University of Basel, Basel, Switzerland; 2000:165.
34. Winstanley PA, Ward SA, Snow RW: Clinical status implication of antimalarial drug resistance. Microb Infect 2002, 4:157-164.
35. Jelinek T, Peyer-Hoffmann G, Mühlberger N, Wichmann O, Wilhelm M, Schmide N, Grobusch MP, von Sonnenburg F, Gascon J, Laferl H, Hartz C, Alifrangis M, Burchard G, McWhinney P, Schulze M, Kollaritsch H, daCunha S, Beran J, Kern P, Gjørup I, Cuadros J: Molecular surveillance of drug resistance through imported isolates of Plasmodium falciparum in Europe. Malar J 2002, 1:11.
36. Hastings MD, Bates SJ, Blackstone EA, Monks SM, Mutabingwa TK, Sibley CH: Highly pyrimethamine-resistant alleles of dihydrofolate reductase in isolates of Plasmodium falciparum from Tanzania. Trans R Soc Trop Med Hyg 2002, 96:674-676.
37. Ahmed A, Bararia D, Vinayak S, Yameen M, Biswas S, Dev V, Kumar A, Ansari M, Sharma YD: Plasmodium isolates in India exhibit a progressive increase in mutations associated with sulphadoxine-pyrimethamine resistance. Antimicrob Agents Chemother 2004, 48:879-889.
38. Jafari S, Le Bras J, Asmar M, Durand R: Molecular survey of Plasmodium falciparum resistance in south-eastern Iran. Ann Trop Med Parasitol 2003, 97:119-124.
39. Takahashi T, Hosoya N, Endo T, Nakamura N, Sakashita H, Kimura K, Ohnishi K, Nakamura Y, Iwamoto A: Relationship betweenmutations in dihydropteroate synthase of Pneumocystis carinii f. sp. hominis isolates in Japan and resistance to sulphonamide therapy. J Clin Microb 2000, 38:3161-3164.
40. Babiker HA, Ranford-Cartwright LC, Walliker D: Theepidemiology of multiple Plasmodium falciparum infections: Genetic structure and dynamics of Plasmodium falciparum infections in the Kilombero region of Tanzania. Trans R Soc Trop Med Hyg 1999, 93:11-14.
41. Clyde DF: Observations on monthly pyrimethamine (Daraprim) prophylaxis in an East African village. East Afr Med J 1954, 3:41-46.
42. Clyde DF, Shute GT: Resistance of Plasmodium falciparum in Tanganyika to pyrimethamine administered at weekly intervals. Trans R Soc Trop Med Hyg 1957, 51:505-513.
43. Rønn AM, Msangeni HA, Mhina J, Wernsdorfer WH, Bygbjerg IC: High level of resistance of Plasmodium falciparum to sulphadoxine-pyrimethamine in children in Tanzania. Trans R Soc Trop Med Hyg 1996, 90:179-181.
44. Mutabingwa T, Nzila A, Mberu E, Nduati E, Winstanley P, Hills E, Watkins W: Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania. Lancet 2001, 358:1218-1223.
45. Swiss Tropical Institute (STI) Report (1999 - 2000): An Overview of STI on Malaria :10-22.
46. Bwijo B, Kaneko A, Takechi M, Zungu IL, Moriyama Y, Lum JK, Tsukahara T, Mita T, Takahashi N, Bergqvist Y, Björkman A, Kobayakawa T: High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulphadoxine and pyrimethamine as first line treatment in Malawi. Acta Trop 2003, 85:363-373.
47. Khalil I, Rønn AM, Alifrangis M, Gabar HA, Satti GMH, Bygbjerg IC: Dihydrofolate reductase and dihydropteroate synthase genotypes associated with in vitro resistance of Plasmodium falciparum to pyrimetamine, trimethoprim, sulphadoxine and sulphamethoxazole. Am J Trop Med Hyg 2003, 68:586-589.
48. Foley M, Ranford-Cartwright LC, Babiker HA: Rapid and simple method for isolating malaria DNA from fingerprick samples of blood. Mol Biochem Parasitol 1992, 53:241-244.